Addus HomeCare Corp (NASDAQ: ADUS)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001468328
Market Cap 2.00 Bn
P/B 1.91
P/E 23.37
P/S 1.49
ROIC (Qtr) 7.43
Div Yield % 0.00
Rev 1y % (Qtr) 25.02
Total Debt (Qtr) 202.49 Mn
Debt/Equity (Qtr) 0.19

About

Addus HomeCare Corp, commonly recognized by its ticker symbol ADUS, is a prominent player in the home care services industry in the United States. The company operates in three primary segments: personal care, hospice, and home health. Established in 1979, Addus has expanded its reach to serve approximately 91,000 discrete consumers across 22 states through its network of around 219 offices. Addus's main business activities revolve around providing home care services, primarily to elderly, chronically ill, or disabled individuals. These services...

Read more

Price action

Investment thesis

Bull case

  • Strong operating cash flow of 103.16M provides robust 0.51x coverage of total debt 202.49M, indicating excellent debt servicing capability and financial flexibility.
  • Healthy cash reserves of 101.92M provide 7.82x coverage of short-term debt 13.03M, demonstrating strong liquidity position and minimal refinancing risk.
  • Robust free cash flow of 96.42M exceeds capital expenditure of 6.75M by 14.29x, indicating strong organic growth funding capability.
  • Retained earnings of 442.56M provide full 2.34x coverage of long-term debt 189.45M, indicating strong internal capital position.
  • Robust tangible asset base of 329.98M provides 3.18x coverage of working capital 103.86M, indicating strong operational backing.

Bear case

  • Operating cash flow of 103.16M barely covers its investment activities of (376.93M), with a coverage ratio of -0.27, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Cash reserves of 101.92M provide limited coverage of acquisition spending of (370.19M), which is -0.28x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • High financing cash flow of 152.83M relative to working capital of 103.86M, which is 1.47x suggests concerning dependence on external funding for operational needs.
  • Tax assets of 0 provide limited offset against tax liabilities of 26.48M, which is 0x, indicating potential future cash flow pressure from tax obligations.
  • R&D investment of 0 represents just 0x of SG&A expenses of 301.02M, indicating potential underinvestment in innovation relative to administrative overhead.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.49 1.26
EV to Cash from Ops. EV/CFO 20.61 12.78
EV to Debt EV to Debt 10.50 12.10
EV to EBIT EV/EBIT 16.42 10.74
EV to EBITDA EV/EBITDA 15.33 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 22.05 18.02
EV to Market Cap EV to Market Cap 1.07 432.64
EV to Revenue EV/Rev 1.58 2.77
Price to Book Value [P/B] P/B 1.90 -1.92
Price to Earnings [P/E] P/E 23.29 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) 8.10 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 29.95 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -54.27 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 20.96 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 17.82 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) 19.86 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) 15.25 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) 6.50 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) -23.74 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 20.17 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.95 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.65 0.39
Current Ratio Curr Ratio (Qtr) 1.66 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.19 -13.19
Interest Cover Ratio Int Coverage (Qtr) 8.10 -97.94
Times Interest Earned Times Interest Earned (Qtr) 8.10 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 10.80 -95.81
EBIT Margin % EBIT Margin % (Qtr) 9.62 -94.97
EBT Margin % EBT Margin % (Qtr) 8.43 -105.60
Gross Margin % Gross Margin % (Qtr) 32.70 23.31
Net Profit Margin % Net Margin % (Qtr) 6.40 -106.14